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Abstract 
Dengue is a mosquito borne disease with worldwide distribution. Depending on virulence factors and
host immune status, infection can manifest as a severe but non fatal viral syndrome or a rapidly
progressive and a frequently fatal haemorrhagic fever. During the course of an outbreak of viral fever
in Karachi, Pakistan from June, 1994 to September, 1995, we studied 145 cases admitted at the Aga
Khan University Hospital. 43% of the cases were between the age group of 20-30 years, majority of
these being male (75%). Amongst the clinical signs and symptoms, the most frequent findings were
fever, vomiting and abdominal pain. Spontaneous hemorrhagic manifestations occurred in 66 patients
and of these petechiae and mucosal bleed were the commonest, that is, 42% and 38% respectively. At
presentation thrombocytopenia (platelet count _50,000) per cubic millimeter) was present in 78%,
leucopenia (white cell count <4,000 per cubic millimeter) in 34%. Apart from one patient who died
from hemorrhagic shock on the 5th day of admission, the remaining patients recovered and their
platelet counts normalized on an average in 9 days. This is the first reported epidemic in Karachi of
dengue infection (JPMA 47:178, 1997).
Introduction 
Dengue is the most important arbovirus disease of humans, in terms of both morbidity and mortality1.
Since the end of World War II, the incidence of deng’ue disease has greatly increased. Coincident with
that increase has been the emergence and spread of a severe and fatal form of the disease. Dengue
Hemorrhagic fever/Dengue Shock Syndrome (DHF/DSS), as a major public health problem in many
areas of the tropics. Today DHF is a leading cause of hospitalization and death among children in many
countries of South East Asia and in recent years, it has become increasingly important in the Pacific
Islands and the Americas. Dengue fever is a human arbovirus infection caused by a ribonucleic acid
(RNA) virus of the Flavivirus genus. There are 4 distinct serotvpe of dengue viruses, capable of
including life long specific immunity and 3 clinical patterns of the disease: a mild atypical form, the
classic dengue and dengue hemorrhagic fever2. In 1986, the World Health Organization (WHO)
defined DHF as an acute febrile disease caused by one of the four serotypes of dengue viruses and
characterised by a bleeding diathesis which may evolve to shock (DSS). Dengue hemorrhagic fever is
generally a secondary infection. Hemoconcentration and thrombocytopenia are frequent findings3. An
extensive epidemic of dengue virus was recognised in Karachi, Pakistan from June, 1994 to September,
1995. Since serologic testing on all patients was not cost effective and laboratoiy facilities for
serotyping were not available, therefore, 16 samples were sent to Singapore and of these, 15 were
positive for IgM against dengue virus. In this communication, we have described various clinical
features present in our cases and also highlighted more effective methods for prevention and control of
dengue infection.
Patients and Methods 
From March, 1994 to September, 1995, we studied 145 cases with clinically suspected dengue fever
admitted at the Aga Khan University Hospital in Karachi, a seaport of Pakistan. 15 of these cases were
serologically proven positive for dengue virus. A retrospective case series was done and frequencies of
various clinical features was studied. Alongwith these we also analysed laboratory data which included
initial complete blood count (taken at admission), daily platelet counts, coagulation profile, liver
function tests and cultures.
Results 
A total of 145 cases of dengue fever were studied, 109 (75%) were males and 36 (25%) were females,
with a mean age of 33 years. Sera of 15 patients belonging to this same series of patients were positive
for IgM Ab against dengue virus. The method used was Enzyme Linked Immunosorbant Assay
(ELISA). Serotyping for subtypes of dengue virus was not done. The clinical features observed in
ourcases are shown in Table I.
Spontaneous hemorrhagic manifestations occurred in 66 patients and of these petechiae and mucosal
bleed were the commonest, that is 42% and 38% respectively, followed by gastrointestinal bleed in 2
1.2%. Of the 28 patients who had rash, 71.5% had petechiae and 28.5% had ecchymoses and from
those who had mucosal bleed, the most predominant site was gumbleed found in 13 of 25 patients.
None ofourpatients gave definite history of exposure to mosquitoes, though 5 cases had a history of
receiving injections prior to admission. From drugs used, 28 of 145 cases, that is 19.3% had taken
Fansidar (an antimalarial) alter the onset of the febrile illness. At presentation, 8 cases had bradycardia
(pulse rate <60 beats per minute) with fever. Rash was found predominantly on the legs in 11 of 28
cases (39.3%) , followed by generalised rash (that is, involving whole body) in 25% of patients. Liver
was palpable in 20 cases (13.7%) and of these 12 cases had deranged liver function tests.
When considering laboratory data, Hematocrit 245% was seen in 47.5% of patients, as shown in Table
II.
Of the patients who had hemoconcentration (Hematocnt 245), 8 had blood pressure <90/60 and 6 of the
8 cases had tachycardia (pulse rate_100 beats per minute). Two patients had clinical manifestations of
dengue shock syndrome, of whom 1 died. One of our cases was aprimigravida in her third trimester
who went on to have a preterm twin vaginal delivery at 33 weeks. Twins were 1.5 kg and 1.9 kg
respectively and did well. Leucopenia (white cell count <4,000 per cubic millimeter)
was found in 34% of patients. At presentation, thrombocytopenia (platelet count <50,000 per cubic
millimeter) was present in 78%. Since thrombocytopenia is a feature of dengue infection, platelet count
was evaluated. Maximal thrombocytopema occurred on day 6to 7 after onset of fever with a mean
platelet count of 21,000 per cubic millimeter. No statistical significance was found between low platelet
count and gastmintestinal bleed (P>0.05). The prothrombin time was normal, that is, 12-14/12 in all the
cases while activated partial thromboplastin tune was abnormal >39 withacontrol of 32 in77%ofcases.
Blood cultures were done in 88 patients and were all negative. Bone marrow cultures were done inS
patients only, all of whom reported no growth. Proteinuria was found in 31 of 53 cases in which a urine
detailed report was done and microscopic hematuria (that is, RBC 4 per high power field) was found in
16 patients (30.2%). Hypoalbuminemia (albumin 3.2 mg/dI-I) was found in 25.7% and
hyperbilirubineniia was seen in 12.8% of cases (bilirubin> 1.25 mg/per decilitre).
Discussion 
Attempts to describe the spectrum of dengue disease and identify risk factors are often difficult because
of the insensitivity of clinical diagnosis, the frequent co-circulation of other viral illnesses and the lack
of adequate laboratory facilities in countries with endemic dengue. Estimates of the number of dengue
cases during both endemic and epidemic periods have generally relied on notification systems based on
clinically diagnosed cases, usually without laboratory verification4. In our study except for 15 cases, all
the rest were identified to have dengue fever on basis of their clinical symptomatology. Initial
investigation of acute phase serafrom 16 patients seen at the Aga Khan University Hospital showed that
15 of them had Dengue Immunoglobulin, M (IgM) antibodies assay using dengue type 2 antigen and
monoclonal antibody5. According to a study in Thailand, IgM Ab shown onELISA had a 97%
sensitivity6. Majority of our cases fell in the age group of 20-40 years which was very different from
that reported in literature where children are said to be most commonly affected by this disease8.
Dengue hemorrhagic fever in Asia is a disease of childhood with one peak observed in children under 1
year and a second in children aged 3 to 5 years7. In the first epidemic of dengue hemorrhagic fever in
Indonesia, most of the cases were in chuldren under 15 years of age. In our study, males were 75%
while reports from Cuba and Brazil8 have shown a predominance of dengue hemorrhagic fever in
women, that is, 65% and 61% respectively. As regards the clinical manifestations of dengue
hemorrhagic fever, experience from numerous outbreaks with laboratory confirmed cases, however, has
shown that the illness associated with dengue infection can differ from country to countiy4. Clinically,
the epidemic was similar to others reported in South East Asia9-14 with a high percentage of patients
suffering from non-specific symptoms such as vomiting and abdominal pain. Although headache has
more frequently been reported as a non-specific symptom in the studies mentioned, was found in only
15.2% of our cases.
In a 1976 dengue epidemic in Indonesia15,backache and joint pain were each reported by only 2.1% of
serologically confirmed dengue cases. Similarly in our study, these symptoms were rarely reported in
4.1% and 0.7% of cases respectively. Bleeding is one of the major problems encountered in dengue
fever and contributes to a worsening morbidity16. In the Island of Tahiti, French Polynesia, severe
hemorrhagic disease was observed in an unusual number of patients shortly after the onset of a febrile
illness. Gastrointestinal bleeding was the most commontype of severe hemorrhage observed and gross
hematuria was next most common17 . In our study, there was one fatality secondaiy to hemorrhage
(upper gastrointestinal bleed) and gastrointestinal bleed was found in 17.3% of cases. Gross hematuria
was reported in only 2 cases. The spectrum of hemorrhagic manifestations observed in Karachi was
comparable to that in other epidemics reported in South East Asia in which petechiae, epistaxis and
hematemesis occurred most frequently9-14. It is important to emphasize the lack of association in our
study between gastrointestinal bleed and low platelet levels, contrary to a significant association
between these two parameters16. Hematopoiesis is affected in dengue hemorrhagic fever, neutropenia
and thrombocytopenia occur early in the disease, coincident with the febrile stage. In our study
leucopenia (white cell count <4,000 per cubic millimeter) was found in 34%of patients and thrombocy
topenia (platelets <50,000 per cubic millimeter) was present in 78% with the lowest platelet count
approaching 2000 per cubic millimeter which is in contrast quite low compared to other studies.
Hepatomegaly was found in 13.7% of cases, that is 20 Fatients. This figure is similar to that reported in
literature15.  On the contrary, higher rates have been reported in Bangkok, Thailand where 80-90% of
confirmed cases had hepatomegaly15. Rates in other countries, however, vary considerably from as low
as 1% in the 1966 Philippine outbreak11, 24% in Burma14, 54-63% in Singapore13 and 66% in
Vietnam12. . It is clear from these reports that hepatomegaly is not a consistent clinical sign associated
with dengue hemorrhagic fever and a closer study of this parameter should be made during epidemics
in different regions and in association with different viruses. Possibly, the extent of liver involvement
may be associated with the strain or serotype of virus15.
Of the 145 cases of dengue hemorrhagic fever, 2 had features consistent with dengue shock syndrome
(DSS), 1 of whom succumbed to the illness. The fatality occurred because of not receiving immediate
treatment, although the patient came to the hospital within hours of onset of shock, demonstrating
urgency of medical assistance in this condition. In conclusion, therapy for dengue fever is supportive.
Immediate and adequate medical assistance pennitted a favourable outcome in most cases. Close
monitoring of the vital signs and hematocrit (not done in our fatality) in order to evaluate plasma loss
or hemorrhage is mandatory to reduce morbidity. If shock develops, aggressive fluid therapy should be
initiated in an intensive care setting. Patients with severe hemorrhage will require transfusions and
careful observation for surgical intervention. Although none of our patients had a history of exposure to
mosquitoes (not that mosquitoes are a variety) but recent dengue epidemics in Brazil18 demonstrate the
need to maintain programmes to reduce population of vector mosquito (Aedes aegyptii, the only known
way of keeping this arbovirus under control).
Prevention and control
Aedes aegyptli is anarthropophilic domestic mosquitoe which lives intimately with its human hosts.
These mosquitoes breed primarily in man-made containers such as water storage containers and flower
vases in and around human dwellings. Elimination of these breeding sites is an effective and definitive
method of controlling the vector and therefore of preventing transmission of dengue. Non-residual
insecticides such as malathion, which kills mosquitoes on contact, have been used in attempts to
control dengue epidemics. New efforts should focus on community education and behaviour
modification in an attempt to encourage neighbourhoods to control the vector through breeding site
reduction. There is no dengue vaccine currently available for widespread public health use. Research
continues on developing an effective and safe tetravalent vaccine that would circumvent the potential
hazards predicted by the immune enhancement theory. Currently the only effective way to avoid
dengue infection in areas where the disease is endemic or epidemic is to avoid being bitten by injected
mosquitoes through the use of insect repellent and other insect barriers19.
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